Norway vs Canada vaccination coverage (% of children aged 12–23 months)
Measles, first dose (MCV1)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 96% | 92% |
| 2023 | 96% | 92% |
| 2022 | 96% | 92% |
| 2021 | 97% | 90% |
| 2020 | 97% | 90% |
| 2019 | 97% | 90% |
| 2018 | 96% | 90% |
| 2017 | 96% | 90% |
| 2016 | 96% | 89% |
| 2015 | 95% | 89% |
| 2014 | 94% | 90% |
| 2013 | 93% | 90% |
| 2012 | 94% | 89% |
| 2011 | 93% | 88% |
| 2010 | 93% | 90% |
| 2009 | 93% | 91% |
| 2008 | 93% | 93% |
| 2007 | 92% | 94% |
| 2006 | 92% | 93% |
| 2005 | 90% | 94% |
| 2004 | 89% | 94% |
| 2003 | 86% | 95% |
| 2002 | 87% | 95% |
| 2001 | 90% | 95% |
| 2000 | 88% | 96% |
| 1999 | 90% | 96% |
| 1998 | 91% | 96% |
| 1997 | 93% | 96% |
| 1996 | 92% | 97% |
| 1995 | 92% | 96% |
| 1994 | 94% | 97% |
| 1993 | 93% | 96% |
| 1992 | 96% | 94% |
| 1991 | 94% | 92% |
| 1990 | 87% | 89% |
| 1989 | 84% | 87% |
| 1988 | 87% | 85% |
| 1987 | 87% | 70% |
| 1986 | 87% | - |
| 1985 | 90% | - |
| 1984 | 80% | - |
| 1983 | 80% | - |
DTP3 (diphtheria, tetanus, whooping cough; third dose)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 97% | 92% |
| 2023 | 96% | 92% |
| 2022 | 97% | 92% |
| 2021 | 97% | 92% |
| 2020 | 97% | 92% |
| 2019 | 97% | 91% |
| 2018 | 96% | 91% |
| 2017 | 96% | 91% |
| 2016 | 96% | 91% |
| 2015 | 95% | 91% |
| 2014 | 93% | 91% |
| 2013 | 94% | 91% |
| 2012 | 95% | 91% |
| 2011 | 94% | 87% |
| 2010 | 93% | 89% |
| 2009 | 94% | 91% |
| 2008 | 94% | 92% |
| 2007 | 93% | 94% |
| 2006 | 94% | 95% |
| 2005 | 91% | 93% |
| 2004 | 92% | 91% |
| 2003 | 92% | 91% |
| 2002 | 93% | 88% |
| 2001 | 91% | 89% |
| 2000 | 90% | 89% |
| 1999 | 92% | 90% |
| 1998 | 93% | 90% |
| 1997 | 95% | 86% |
| 1996 | 97% | 90% |
| 1995 | 97% | 87% |
| 1994 | 93% | 93% |
| 1993 | 94% | 90% |
| 1992 | 98% | 89% |
| 1991 | 96% | 88% |
| 1990 | 86% | 88% |
| 1989 | 83% | 87% |
| 1988 | 83% | 86% |
| 1987 | 80% | 85% |
| 1986 | 83% | - |
| 1985 | 85% | - |
| 1984 | 90% | - |
| 1983 | 90% | - |
Hepatitis B, third dose (HepB3)
| Year | % of children | |
|---|---|---|
|
|
|
|
| 2024 | 96% | 83% |
| 2023 | 96% | 83% |
| 2022 | 96% | 83% |
| 2021 | 96% | 84% |
| 2020 | 97% | 84% |
| 2019 | 96% | 84% |
| 2018 | - | 71% |
| 2017 | - | 71% |
| 2016 | - | 70% |
| 2015 | - | 69% |
| 2014 | - | 55% |
| 2013 | - | 55% |
| 2012 | - | 70% |
| 2011 | - | 70% |
| 2010 | - | 56% |
| 2009 | - | 42% |
| 2008 | - | 28% |
| 2007 | - | 14% |
| 2006 | - | 14% |
| 2005 | - | 14% |
| 2004 | - | 14% |
| 2003 | - | 14% |
| 2002 | - | - |
| 2001 | - | - |
| 2000 | - | - |
| 1999 | - | - |
| 1998 | - | - |
| 1997 | - | - |
| 1996 | - | - |
| 1995 | - | - |
| 1994 | - | - |
| 1993 | - | - |
| 1992 | - | - |
| 1991 | - | - |
| 1990 | - | - |
| 1989 | - | - |
| 1988 | - | - |
| 1987 | - | - |
| 1986 | - | - |
| 1985 | - | - |
| 1984 | - | - |
| 1983 | - | - |
The first measles dose reaches 96% of children aged 12–23 months in Norway and 92% in Canada: 4 percentage points more in Norway. The third DTP dose reaches 97% in Norway and 92% in Canada, 5 points more in Norway. The third hepatitis B dose reaches 96% in Norway and 83% in Canada, 13 points more in Norway. In 1987, the first measles dose reached 87% in Norway and 70% in Canada, 17 percentage points more in Norway.
Norway vs Canada: latest vaccination coverage (% of children aged 12–23 months)
|
|
|
|
|---|---|---|
| Measles (MCV1) | 96% (2024) | 92% (2024) |
| DTP3 | 97% (2024) | 92% (2024) |
| HepB3 | 96% (2024) | 83% (2024) |
Norway and its neighbors: measles vaccination (MCV1), % of children aged 12–23 months
Canada and nearby countries: measles vaccination (MCV1), % of children aged 12–23 months
Of Norway and its three neighbors, the latest coverage of the first measles dose is highest in Russia, at 97%, and lowest in Sweden, at 93%; of Canada and the five nearby countries, the latest coverage of the first measles dose is highest in Cuba, at 99%, and lowest in Mexico, at 80%.
Compare the vaccination rates of any 2 countries
Sources:
- World Bank | Health (1983–2024, updated October 2026)
Creative Commons Attribution (CC BY): you may copy, share, adapt and reuse this content, also commercially, as long as you credit statistics.wiki and note any changes you made. The sources listed above may have their own license terms.